https://interhospi.com/wp-content/uploads/sites/3/2025/06/MIM-Encore.jpg
594
1056
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-06-27 12:45:422025-06-27 12:45:42GE HealthCare advances precision imaging with MIM Encore platform
https://interhospi.com/wp-content/uploads/sites/3/2025/06/GE-Omni-Legend.jpg
1650
2475
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-06-27 12:40:382025-06-27 12:40:38GE HealthCare advances cardiac PET diagnostics with Flyrcado launch
https://interhospi.com/wp-content/uploads/sites/3/2025/06/skylabs_2.jpg
310
468
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-06-24 11:56:402025-06-24 11:56:40Sky Labs cuffless blood pressure monitor gains recognition
https://interhospi.com/wp-content/uploads/sites/3/2025/06/Sir-Peter-Donnelly.jpg
566
600
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-06-24 11:50:442025-06-24 11:50:44Genomics launches predictive Health Insights test in UK
https://interhospi.com/wp-content/uploads/sites/3/2025/06/Philips-Flash-Ultrasound-System-5100-POC.jpg
620
885
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-06-23 10:35:322025-06-23 10:35:32Philips launches Flash 5100 POC ultrasound system
https://interhospi.com/wp-content/uploads/sites/3/2025/06/gadoquatrane.jpg
958
1034
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-06-08 06:38:132025-06-08 06:38:13Bayer submits low-dose MRI contrast agent gadoquatrane for Japan approval
https://interhospi.com/wp-content/uploads/sites/3/2025/06/chest_pain.jpeg
667
1000
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-06-02 13:02:082025-06-02 13:05:22Roche receives CE mark for chest pain triage algorithm
https://interhospi.com/wp-content/uploads/sites/3/2025/06/diagnostics-ai.jpg
581
1000
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-06-02 12:26:102025-06-02 13:04:02Diagnostics.ai launches first CE-IVDR transparent AI platform
A pioneering five-year research programme to develop the foundational tools for synthesising human genomes has launched with £10mn funding from Wellcome. The ambitious Synthetic Human Genome project, led by Professor Jason Chin at the MRC Laboratory of Molecular Biology, aims to unlock transformative biotechnology applications and accelerate targeted cell-based therapies.
Healthcare technology strategist Melinda Yormick explores how real-time data integration represents a critical breakthrough in hospital operational efficiency. Her analysis reveals how precision operations – enabled by automated workflow monitoring and live analytics – could transform fragmented healthcare systems into coordinated, responsive care environments, fundamentally improving patient outcomes and resource allocation across critical departments.
Researchers have assembled the most comprehensive genetic atlas of cannabis to date, revealing unprecedented molecular diversity that could revolutionise medicinal applications and unlock novel therapeutic compounds. The landmark study, published in Nature on 28 May 2025, analysed 193 cannabis genomes and identified surprising genetic variation that may hold the key to developing new cannabinoid-based treatments.
In a Genomic Psychiatry interview, Professor Barbara Franke reveals how her revolutionary interdisciplinary approach is transforming ADHD research. Her innovative methodology combines cutting-edge genomics, experimental models, and international collaboration to decode biological pathways from genetic variations to behavioural changes, offering unprecedented insights for personalised neurodevelopmental treatments.
interhospi.com
The online source of medical device information connecting healthcare professionnals to global vendors.
clinlabint.com
Clinical Laboratory International (CLI) has been at the forefront of communication in the clinical chemistry and diagnostics
market for over 40 years.
cars-int.org
Founded in 1983, CARS is focusing on research and development on novel algorithms and systems and their applications in radiology and surgery.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Salk Institute
Barbara Franke, PhD
Healthcare LLM AI systems show dangerous bias against women patients
LLMs, patient safety, /in AI, E-News /by panglobalLarge Language Model (LLM) artificial intelligence systems increasingly deployed across healthcare settings pose serious risks to patient safety, with new research revealing these tools systematically recommend reduced medical care for women and vulnerable populations based on irrelevant factors such as typing errors and communication style rather than clinical need.
HLTH Europe: Healthcare reimagined
HLTH Europe 2025, /in E-News, Events /by panglobalHLTH Europe represents a paradigm shift in healthcare innovation conferences, establishing itself as the continent’s premier forum for addressing complex systemic challenges across the medical ecosystem. Held 15-18 June at Amsterdam’s RAI Convention Centre, this landmark event brought together more than 5,000 attendees from 50+ countries to tackle healthcare’s most pressing issues through collaborative innovation. […]
Philips Future Health Index report reveals healthcare AI trust gap
Philips, /in AI, E-News /by panglobalA comprehensive global survey commissioned by Philips has identified substantial trust disparities between healthcare professionals and patients regarding artificial intelligence implementation in medical care, with professionals showing significantly greater optimism about AI’s potential to improve patient outcomes.
Novel synthetic compound shows promise against drug-resistant bacteria
AMR, antibiotic resistance, infuzide, /in E-News, pharmacology /by panglobalResearchers have developed a novel synthetic compound called infuzide that shows promising activity against multidrug-resistant bacterial infections. The compound demonstrated effectiveness against resistant strains of Staphylococcus aureus and Enterococcus species in both laboratory and mouse studies, potentially offering a new therapeutic approach for treating serious hospital-acquired infections.